Biotechnology
Compare Stocks
2 / 10Stock Comparison
FTRE vs PRA
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Property & Casualty
FTRE vs PRA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Insurance - Property & Casualty |
| Market Cap | $1.47B | $1.27B |
| Revenue (TTM) | $2.71B | $1.08B |
| Net Income (TTM) | $-447M | $65M |
| Gross Margin | 12.1% | 25.5% |
| Operating Margin | -1.1% | 8.4% |
| Forward P/E | 23.0x | 21.8x |
| Total Debt | $68M | $435M |
| Cash & Equiv. | $175M | $36M |
FTRE vs PRA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 23 | May 26 | Return |
|---|---|---|---|
| Fortrea Holdings In… (FTRE) | 100 | 45.8 | -54.2% |
| ProAssurance Corpor… (PRA) | 100 | 163.1 | +63.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FTRE vs PRA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FTRE is the clearest fit if your priority is growth exposure.
- Rev growth 1.0%, EPS growth -194.6%, 3Y rev CAGR -1.4%
- 1.0% revenue growth vs PRA's -2.7%
- +176.6% vs PRA's +7.2%
PRA carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 0 yrs, beta 0.05
- -18.8% 10Y total return vs FTRE's -51.3%
- Lower volatility, beta 0.05, Low D/E 32.2%, current ratio 1.33x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.0% revenue growth vs PRA's -2.7% | |
| Value | Lower P/E (21.8x vs 23.0x) | |
| Quality / Margins | 6.0% margin vs FTRE's -16.5% | |
| Stability / Safety | Beta 0.05 vs FTRE's 2.35 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +176.6% vs PRA's +7.2% | |
| Efficiency (ROA) | 1.2% ROA vs FTRE's -16.3%, ROIC 3.2% vs -1.6% |
FTRE vs PRA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FTRE vs PRA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PRA leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
FTRE is the larger business by revenue, generating $2.7B annually — 2.5x PRA's $1.1B. PRA is the more profitable business, keeping 6.0% of every revenue dollar as net income compared to FTRE's -16.5%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.7B | $1.1B |
| EBITDAEarnings before interest/tax | $48M | $101M |
| Net IncomeAfter-tax profit | -$447M | $65M |
| Free Cash FlowCash after capex | $215M | -$17M |
| Gross MarginGross profit ÷ Revenue | +12.1% | +25.5% |
| Operating MarginEBIT ÷ Revenue | -1.1% | +8.4% |
| Net MarginNet income ÷ Revenue | -16.5% | +6.0% |
| FCF MarginFCF ÷ Revenue | +8.0% | -1.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.3% | -2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +95.9% | +2.5% |
Valuation Metrics
PRA leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, PRA's 19.5x EV/EBITDA is more attractive than FTRE's 28.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $1.5B | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $1.4B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -1.44x | 24.86x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.00x | 21.76x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 28.82x | 19.46x |
| Price / SalesMarket cap ÷ Revenue | 0.54x | 1.16x |
| Price / BookPrice ÷ Book value/share | 2.52x | 0.94x |
| Price / FCFMarket cap ÷ FCF | 16.68x | — |
Profitability & Efficiency
PRA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
PRA delivers a 5.0% return on equity — every $100 of shareholder capital generates $5 in annual profit, vs $-79 for FTRE. FTRE carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRA's 0.32x. On the Piotroski fundamental quality scale (0–9), FTRE scores 4/9 vs PRA's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -79.1% | +5.0% |
| ROA (TTM)Return on assets | -16.3% | +1.2% |
| ROICReturn on invested capital | -1.6% | +3.2% |
| ROCEReturn on capital employed | -1.4% | +4.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.12x | 0.32x |
| Net DebtTotal debt minus cash | -$107M | $399M |
| Cash & Equiv.Liquid assets | $175M | $36M |
| Total DebtShort + long-term debt | $68M | $435M |
| Interest CoverageEBIT ÷ Interest expense | -7.33x | 4.53x |
Total Returns (Dividends Reinvested)
PRA leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PRA five years ago would be worth $9,679 today (with dividends reinvested), compared to $4,866 for FTRE. Over the past 12 months, FTRE leads with a +176.6% total return vs PRA's +7.2%. The 3-year compound annual growth rate (CAGR) favors PRA at 9.7% vs FTRE's -21.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -7.4% | +2.5% |
| 1-Year ReturnPast 12 months | +176.6% | +7.2% |
| 3-Year ReturnCumulative with dividends | -51.3% | +32.0% |
| 5-Year ReturnCumulative with dividends | -51.3% | -3.2% |
| 10-Year ReturnCumulative with dividends | -51.3% | -18.8% |
| CAGR (3Y)Annualised 3-year return | -21.3% | +9.7% |
Risk & Volatility
PRA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PRA is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than FTRE's 2.35 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PRA currently trades 99.0% from its 52-week high vs FTRE's 83.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.35x | 0.05x |
| 52-Week HighHighest price in past year | $18.67 | $24.85 |
| 52-Week LowLowest price in past year | $3.97 | $22.72 |
| % of 52W HighCurrent price vs 52-week peak | +83.4% | +99.0% |
| RSI (14)Momentum oscillator 0–100 | 82.8 | 48.4 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 793K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates FTRE as "Hold" and PRA as "Hold". Consensus price targets imply 20.9% upside for FTRE (target: $19) vs -25.5% for PRA (target: $18).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $18.83 | $18.33 |
| # AnalystsCovering analysts | 12 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
PRA leads in 5 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics.
FTRE vs PRA: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is FTRE or PRA a better buy right now?
For growth investors, Fortrea Holdings Inc.
(FTRE) is the stronger pick with 1. 0% revenue growth year-over-year, versus -2. 7% for ProAssurance Corporation (PRA). ProAssurance Corporation (PRA) offers the better valuation at 24. 9x trailing P/E (21. 8x forward), making it the more compelling value choice. Analysts rate Fortrea Holdings Inc. (FTRE) a "Hold" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FTRE or PRA?
On forward P/E, ProAssurance Corporation is actually cheaper at 21.
8x.
03Which is the better long-term investment — FTRE or PRA?
Over the past 5 years, ProAssurance Corporation (PRA) delivered a total return of -3.
2%, compared to -51. 3% for Fortrea Holdings Inc. (FTRE). Over 10 years, the gap is even starker: PRA returned -18. 8% versus FTRE's -51. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FTRE or PRA?
By beta (market sensitivity over 5 years), ProAssurance Corporation (PRA) is the lower-risk stock at 0.
05β versus Fortrea Holdings Inc. 's 2. 35β — meaning FTRE is approximately 4801% more volatile than PRA relative to the S&P 500. On balance sheet safety, Fortrea Holdings Inc. (FTRE) carries a lower debt/equity ratio of 12% versus 32% for ProAssurance Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — FTRE or PRA?
By revenue growth (latest reported year), Fortrea Holdings Inc.
(FTRE) is pulling ahead at 1. 0% versus -2. 7% for ProAssurance Corporation (PRA). On earnings-per-share growth, the picture is similar: ProAssurance Corporation grew EPS -3. 9% year-over-year, compared to -194. 6% for Fortrea Holdings Inc.. Over a 3-year CAGR, PRA leads at -0. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FTRE or PRA?
ProAssurance Corporation (PRA) is the more profitable company, earning 4.
6% net margin versus -36. 2% for Fortrea Holdings Inc. — meaning it keeps 4. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PRA leads at 6. 6% versus -1. 1% for FTRE. At the gross margin level — before operating expenses — PRA leads at 39. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FTRE or PRA more undervalued right now?
On forward earnings alone, ProAssurance Corporation (PRA) trades at 21.
8x forward P/E versus 23. 0x for Fortrea Holdings Inc. — 1. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FTRE: 20. 9% to $18. 83.
08Which pays a better dividend — FTRE or PRA?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is FTRE or PRA better for a retirement portfolio?
For long-horizon retirement investors, ProAssurance Corporation (PRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05)). Fortrea Holdings Inc. (FTRE) carries a higher beta of 2. 35 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PRA: -18. 8%, FTRE: -51. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FTRE and PRA?
These companies operate in different sectors (FTRE (Healthcare) and PRA (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.